Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease.

Haixia RenJian KangJing WangJuan SuLiping ZouAnning YinJiao LiQian ZhouWei WangZhishun TangJing ZhangYueyue LuYuanping YangChengen QiuYijuan DingWeiguo Dong Ping An

Published in: Inflammatory bowel diseases (2023)

Optimization of ustekinumab by 2 initial intravenous inductions is more effective than standard therapy for adult patients with severe CD.

Keyphrases

high dose
early onset